公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2016 | 2-(Phenylsulfonyl)quinoline N-hydroxyacrylamides as potent anticancer agents inhibiting histone deacetylase | Lee H.-Y.; Chang C.-Y.; Su C.-J.; Huang H.-L.; Mehndiratta S.; Chao Y.-H.; Hsu C.-M.; Kumar S.; Sung T.-Y.; Huang Y.-Z.; Li Y.-H.; CHIA-RON YANG ; Liou J.-P. | European Journal of Medicinal Chemistry | 25 | 24 | |
2018 | The anticancer effects of MPT0G211, a novel HDAC6 inhibitor, combined with chemotherapeutic agents in human acute leukemia cells | Tu H.-J.; Lin Y.-J.; Chao M.-W.; Sung T.-Y.; Wu Y.-W.; Chen Y.-Y.; Lin M.-H.; Liou J.-P.; Pan S.-L.; CHIA-RON YANG | Clinical Epigenetics | 21 | 21 | |
2022 | Discovery of a novel cyclin-dependent kinase 8 inhibitor with an oxindole core for anti-inflammatory treatment | Lin T.E.; CHIA-RON YANG ; Chou C.-H.; Hsu J.-Y.; Chao M.-W.; Sung T.-Y.; Hsieh J.-H.; Huang W.-J.; Hsu K.-C. | Biomedicine and Pharmacotherapy | 6 | 4 | |
2022 | Identification and analysis of a selective DYRK1A inhibitor | Lin T.E.; Chao M.-W.; HuangFu W.-C.; Tu H.-J.; Peng Z.-X.; Su C.-J.; Sung T.-Y.; Hsieh J.-H.; Lee C.-C.; CHIA-RON YANG ; Pan S.-L.; Hsu K.-C. | Biomedicine and Pharmacotherapy | 6 | 3 | |
2021 | Identification of a dual TAOK1 and MAP4K5 inhibitor using a structure-based virtual screening approach | Chao M.-W.; Lin T.E.; HuangFu W.-C.; Chang C.-D.; Tu H.-J.; Chen L.-C.; Yen S.-C.; Sung T.-Y.; Huang W.-J.; CHIA-RON YANG ; Pan S.-L.; Hsu K.-C. | Journal of Enzyme Inhibition and Medicinal Chemistry | 9 | 8 | |
2015 | Mining missing membrane proteins by high-ph reverse-phase stagetip fractionation and multiple reaction monitoring mass spectrometry | Kitata R.B.; Dimayacyac-Esleta B.R.-T. ; Choong W.-K.; Tsai C.-F.; Lin T.-D.; Tsou C.-C.; Weng S.-H.; Chen Y.-J.; PAN-CHYR YANG ; Arco S.-D.; Nesvizhskii A.-I.; Sung T.-Y.; Chen Y.-J. | Journal of Proteome Research | 25 | 24 | |
2019 | MPT0G413, A novel HDAC6-selective inhibitor, and bortezomib synergistically exert anti-tumor activity in multiple myeloma cells | Huang F.-I.; Wu Y.-W.; Sung T.-Y.; Liou J.-P.; Lin M.-H.; Pan S.-L.; CHIA-RON YANG | Frontiers in Oncology | 19 | 18 | |
2022 | O-methylated flavonol as a multi-kinase inhibitor of leukemogenic kinases exhibits a potential treatment for acute myeloid leukemia | Yen S.-C.; Wu Y.-W.; Huang C.-C.; Chao M.-W.; Tu H.-J.; Chen L.-C.; Lin T.E.; Sung T.-Y.; Tseng H.-J.; Chu J.-C.; Huang W.-J.; CHIA-RON YANG ; HuangFu W.-C.; Pan S.-L.; Hsu K.-C. | Phytomedicine | 5 | 5 | |
2011 | Phosphoproteomics identifies oncogenic ras signaling targets and their involvement in lung adenocarcinomas | Sudhir P.-R.; CHIA-LANG HSU ; Wang M.-J.; Wang Y.-T.; Chen Y.-J.; Sung T.-Y.; Hsu W.-L.; Yang U.-C.; Chen J.-Y. | PLoS ONE | 32 | 31 | |
2017 | Phosphoproteomics Reveals HMGA1, a CK2 Substrate, as a Drug-Resistant Target in Non-Small Cell Lung Cancer | YUN-TUNG WANG ; SZU-HUA PAN ; CHEN-FENG TSAI ; TING-CHUN KUO ; Hsu Y.-L.; Yen H.-Y.; Choong W.-K.; Wu H.-Y.; Liao Y.-C.; Hong T.-M.; Sung T.-Y.; PAN-CHYR YANG ; Chen Y.-J. | Scientific Reports | 25 | 25 | |
2022 | Structure-based virtual screening and biological evaluation of novel small-molecule BTK inhibitors | Lin T.E.; Sung L.-C.; Chao M.-W.; Li M.; Zheng J.-H.; Sung T.-Y.; Hsieh J.-H.; CHIA-RON YANG ; Lee H.-Y.; Cho E.-C.; Hsu K.-C. | Journal of Enzyme Inhibition and Medicinal Chemistry | 3 | 3 |